Biogen paid its 5 named executives $52.7M in total in FY2025 (Dec). CEO Christopher A. Viehbacher was paid $23.6M of that.
Pay$100 in the stock at the end of FY21 → $73
Pay of each named executive
Christopher A. ViehbacherPresident and CEO
| FY2025 (Dec) | Not disclosed | ||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed |
4 years
Susan H. AlexanderExecutive Vice President, Chief Legal Officer
| FY2025 (Dec) | Not disclosed | ||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Nicole C. MurphyHead of Pharmaceutical Operations and Technology
| FY2025 (Dec) | Not disclosed | ||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed |
4 years
Priya A. SinghalHead of Development
| FY2025 (Dec) | Not disclosed | ||||||
| FY2024 (Dec) |
2 years
Michael R. McdonnellExecutive Vice President, Chief Financial Officer
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
4 years
Robin C. KramerExecutive Vice President and Chief Financial Officer
| FY2025 (Dec) |
1 year
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.